Clinical Trial Update: To Evaluate Efficacy and Safety of TopicalKX-826 Solution in Chinese Male Patients With Androgenetic Alopecia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for TopicalKX-826 Solution in Chinese male patients with androgenetic alopecia. Phase 2 and Phase 3 studies are not yet recruiting and are…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• TopicalKX-826 Solution (KX-826 topical solution)

Snippet

Sponsor: Suzhou Kintor Pharmaceutical Inc, | Conditions: Androgenetic Alopecia (AGA) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING